| Profile | GDS1873 / 218606_at |
| Title | Antiestrogen and aromatase inhibitor effect on breast cancer cells |
| Organism | Homo sapiens |
| Sample | Title | Value | Rank |
|---|---|---|---|
| GSM40787 | control - Rep 1 | 1478.27 | 92 |
| GSM40788 | control - Rep 2 | 2377.07 | 96 |
| GSM40789 | control - Rep 3 | 1944.48 | 95 |
| GSM40775 | androgen treated - Rep 1 | 1749.38 | 94 |
| GSM40776 | androgen treated - Rep 2 | 1824.26 | 94 |
| GSM40777 | androgen treated - Rep 3 | 1371.61 | 92 |
| GSM40790 | estrogen treated - Rep 1 | 1318.84 | 92 |
| GSM40791 | estrogen treated - Rep 2 | 1355.35 | 92 |
| GSM40792 | estrogen treated - Rep 3 | 1735.07 | 94 |
| GSM40784 | A + tamoxifen - Rep 1 | 1648.76 | 93 |
| GSM40785 | A + tamoxifen - Rep 2 | 1505.41 | 93 |
| GSM40786 | A + tamoxifen - Rep 3 | 2081.52 | 95 |
| GSM40778 | A + anastrozole - Rep 1 | 1760.4 | 95 |
| GSM40779 | A + anastrozole - Rep 2 | 1361.3 | 91 |
| GSM40780 | A + anastrozole - Rep 3 | 1865.35 | 94 |
| GSM40781 | A + letrozole - Rep 1 | 1366.65 | 93 |
| GSM40782 | A + letrozole - Rep 2 | 1562.29 | 93 |
| GSM40783 | A + letrozole - Rep 3 | 1750.05 | 94 |